Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Global Antibacterial Drugs Market - 2023-2030
... can also interact with other drugs, raising or lowering serum levels of other drugs by increasing or decreasing their metabolism. An antibiotic with bactericidal activity can improve bacterial killing when host defenses are impaired locally ... Read More
-
Global Pharmaceutical Visual Inspection Systems Market 2024 - 2031
... An inspection machine is mostly helpful to the pharmaceutical sector. It has numerous other applications in the nutraceutical and nutritional supplement industries. It works well as a capsule sorting device that removes flawed capsules. Typically, ... Read More
-
Scopolamine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
... fall in surgical volume during the pandemic hampered the scopolamine market's growth. For instance, according to an article published in Jama Network in April 2021, an article reported that the frequency of surgical procedures throughout ... Read More
-
Empty Capsules Global Market Report 2025 Including: 1) By Type: Gelatin Capsules; Non-Gelatin Capsules 2) By Functionality: Immediate-Release Capsules; Sustained-Release Capsules; Delayed-release Capsules 3) By Application: Antibiotic And Antibacterial Drugs; Dietary Supplements; Antacid And Antiflatulent Preparations; Antianemic Preparations; Anti-inflammatory Drugs; Cardiovascular Therapy Drugs; Cough And Cold Drug Preparations 4) By End-User: Pharmaceutical Industry; Nutraceutical Industry; Cosmetic Industry; Research Laboratories Covering: ACG Group; CapsCanada Corporation; HealthCaps India Limited; Natural Capsules Ltd.; Bright Pharma Caps Inc.
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Non-alcoholic Steatohepatitis Supplements Market - 2023-2030
... is growing at a CAGR of 3.8% during the forecast period (2023-2030). Non-Alcoholic Steatohepatitis is a type of liver disease in which fat accumulates in the livers of people who do not consume alcohol. This ... Read More
-
Global Oral Transmucosal Drugs Market- 2023-2030
... to exhibit a CAGR of 6.4% during the forecast period (2023-2030). Oraltransmucosal drug administration was an alternative route in end-of-life care and palliative care during the COVID-19 pandemic. Oral transmucosal drug delivery is the systemic ... Read More
-
2025 Testing Services for Pharmaceutical, Medical Devices, and Personal Care Products Global Market Size & Growth Report with Updated Analysis & Forecasts
... Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling ... Read More
-
Pharmaceuticals in Mexico: ISIC 2423
... level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - ... Read More
-
Global Astaxanthin Market – Sources, Technologies and Applications
... various health conditions, including inflammation, diabetes, cardiovascular issues, vision problems, and central nervous system disorders. Widely utilized across industries, astaxanthin is used in aquaculture to enhance the pigmentation of salmon, trout, and shrimp; in nutraceuticals ... Read More
-
Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Region 2025-2033
... 2025-2033. The rising prevalence of hormonal disorders, increased awareness and acceptance of HRT, expanding geriatric population, significant technological advancements and ongoing innovations in delivery methods, supportive government initiatives and reimbursement policies are some of the ... Read More
-
Amaranth Seed Oil Market Size, Share, and Outlook, 2025 Report- By Extraction (Cold Pressed, Organic Solvent, Super Critical CO2 Extraction, Others), By Application (Cosmetics, Food Supplements, Pharmaceutical, Fragrance/Aromatics, Others), 2018-2032
... robust Amaranth Seed Oil Market growth presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Amaranth Seed Oil Market segments across ... Read More
-
Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2025-2033
... 2025-2033. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market. ... Read More
-
Guar Gum Powder Market Report by Grade (Food-Grade, Industrial-Grade, Pharmaceutical-Grade), Function (Thickening, Gelling, Binding, Friction Reducing, and Other Functions), End Use Industry (Oil Drilling, Food Industry, Paper and Textile, Pharmaceuticals, Cosmetics, and Others), and Region 2025-2033
... 2025-2033. The rising prevalence of convenience and ready-to-eat (RTE) food items, increasing adoption in pharmaceuticals, and the growing usage of industrial-grade product variants represent some of the key factors driving the market. Guar gum powder ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted their strategic focus to more lucrative therapy areas, such as rare diseases ... Read More
-
Chemotherapy-induced Nausea and Vomiting Drugs
... Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Serotonin Receptor Antagonist, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$2.0 ... Read More
-
Fill Finish Manufacturing
... at a CAGR of 8.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Dosing Systems
... CAGR of 4.6% over the analysis period 2024-2030. Diaphragm Dosing Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$5.6 Billion by the end of the ... Read More
-
Pharmaceutical Excipients
... CAGR of 4.5% over the analysis period 2024-2030. Organic Chemicals, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.8 Billion by the end of the analysis ... Read More
-
Sterile Medical Packaging
... at a CAGR of 7.3% over the analysis period 2024-2030. Plastics Material, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.5 Billion by the end of ... Read More
-
Isosorbide
... 7.4% over the analysis period 2024-2030. PEIT Application, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$439.5 Million by the end of the analysis period. Growth ... Read More
-
Non-alcoholic Steatohepatitis (NASH)
... at a CAGR of 55.7% over the analysis period 2024-2030. Vitamin E & Pioglitazone Drugs, one of the segments analyzed in the report, is expected to record a 45.3% CAGR and reach US$59.7 Billion by ... Read More
-
Pharmaceutical Hot Melt Extrusion Equipment
... Million by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Twin Screw Extruders, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$28.0 ... Read More
-
Manual Filling Equipment
... at a CAGR of 6.7% over the analysis period 2024-2030. Food & Beverages End-Use, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.1 Billion by the ... Read More
-
Anticholinergic Drugs
... CAGR of 5.0% over the analysis period 2024-2030. Synthetic Compounds, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$6.6 Billion by the end of the analysis ... Read More
-
Sodium Alginate
... CAGR of 5.0% over the analysis period 2024-2030. Stabilizers Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$137.4 Million by the end of the analysis ... Read More
Research Assistance
